Infinity Pharmaceuticals Inc (NASDAQ:INFI)

1.19
Delayed Data
As of Sep 30
 -0.01 / -0.83%
Today’s Change
0.46
Today|||52-Week Range
3.42
-47.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues109.1M18.7M6.0M22.1M
 
 
 
 
 
Depreciation And Amortization2.3M3.4M1.7M191.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses233.9M139.9M40.7M33.9M
 
 
 
 
 
Research And Development199.1M106.9M20.8M19.8M
 
 
 
 
 
Total Operating Expenses236.2M143.3M42.4M34.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-127.1M-124.6M-36.4M-11.9M
 
 
 
 
 
Extraordinary Credit0.00114.9M0.000.00
 
 
Extraordinary Charge0.00-21.2M-6.9M0.00
 
 
 
Interest Expense On Debt1.4M1.2M1.0M93.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-128.0M-30.1M-42.6M-11.3M
 
 
 
 
 
Income Taxes-335.0K0.00-720.0K0.00
 
 
 
Net Income-128.4M-30.1M-41.8M-11.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.1M49.6M50.6M55.4M
 
 
 
 
 
Shares To Calculate EPS Diluted49.1M49.6M50.6M55.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.62-$0.61-$0.83-$0.20
 
 
 
 
 
EPS Diluted-$2.62-$0.61-$0.83-$0.20